| FIX | 1.18% | 689.03 | +1.17% | 3,640 | |
| INSM | 1.12% | 131.37 | +1.48% | 18,478 | |
| TPR | 1.03% | 98.20 | -0.68% | 21,506 | |
| FLEX | 0.92% | 49.29 | +0.39% | 39,537 | |
| FFIV | 0.89% | 315.08 | -0.22% | 5,961 | |
| BURL | 0.87% | 273.72 | -1.29% | 6,531 | |
| NTNX | 0.84% | 68.08 | -2.23% | 25,824 | |
| GEN | 0.84% | 31.27 | -0.56% | 56,340 | |
| USFD | 0.83% | 77.16 | -2.09% | 22,864 | |
| CRDO | 0.82% | 110.65 | +4.40% | 14,838 |
New York Life Investments ETF Trust - NYLI Candriam U.S. Mid Cap Equity ETF is an exchange traded fund launched and managed by New York Life Investment Management LLC. The fund invests in public equity markets of the United States. It invests in stocks of companies operating across diversified sectors. The fund invests in growth and value stocks of mid-cap companies. It invests in stocks of companies that are deemed socially conscious in their business dealings and directly promote environmental responsibility. The fund seeks to track the performance of the NYLI Candriam U.S. Mid Cap Equity Index, by using full replication technique. The fund does not invest in stocks of companies operating across oppressive regimes, adult content, alcohol, armament, gambling, nuclear, and tobacco sectors, or that utilize animal testing or genetic modification in research and development sectors. New York Life Investments ETF Trust - NYLI Candriam U.S. Mid Cap Equity ETF was formed on October 25, 2022 and is domiciled in the United States.